Startup Brain.Q’s trials show promising results for stroke patients
ISRAELI startup Brain.Q said on Thursday (May 16) it had promising results from a clinical trial that uses an artificial intelligence-powered electromagnetic field therapy to help reduce disabilities in people after suffering a stroke.
The trial for its brain stimulation therapy at 15 US academic centres targeted severe ischemic stroke patients and was conducted as a daily session in the weeks following a stroke.
“The welcome results from this study suggest there is a chance that even severe stroke patients may be able to regain freedom from disability with this therapy,” said Jeffrey Saver, director of stroke at UCLA, who was co-principal for the study.
Brain.Q is developing a cloud-based platform to map brain network activity using machine learning algorithms to extract biological insights that translate into therapies.
The therapies are delivered via a portable medical device patients wear over their heads that creates a low-intensity electromagnetic field.
Although not reaching statistical significance, results showed, Brain.Q said, that patients receiving the treatment are more likely to have a greater reduction in their disability levels following the stroke compared with patients receiving the placebo treatment.
SEE ALSO
The trial’s findings suggested that actively treated patients were also more than twice as likely to be free from disability at three months, and may go back to live independently and return to work.
The company will launch a second trial this summer in the US where it has received Breakthrough Device Designation by the US Food and Drug Administration. REUTERS
Share with us your feedback on BT's products and services
